Related Experiment Video
Updated: Jul 15, 2026

A Protocol for Functional Assessment of Whole-Protein Saturation Mutagenesis Libraries Utilizing High-Throughput Sequencing
Published on: July 3, 2016
Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases
Yu Chen1, Brian Shoichet, Richard Bonnet
1Department of Pharmaceutical Chemistry, University of California, San Francisco, Genentech Hall, 600 16th Street, San Francisco, California 94143-2240, USA.
Abstract:
CTX-M enzymes are an emerging group of extended spectrum beta-lactamases (ESBLs) that hydrolyze not only the penicillins but also the first-, second-, and third-generation cephalosporins. Although they have become the most frequently observed ESBLs in certain areas, there are few effective inhibitors and relatively little is known about their detailed mechanism. Here we describe the X-ray crystal structures of CTX-M enzymes in complex with different transition-state analogues and beta-lactam inhibitors, representing the enzyme as it progresses from its acylation transition state to its acyl enzyme complex to the deacylation transition state. As the enzyme moves along this reaction coordinate, two key catalytic residues, Lys73 and Glu166, change conformations, tracking the state of the reaction. Unexpectedly, the acyl enzyme complex with the beta-lactam inhibitor cefoxitin still has the catalytic water bound; this water had been predicted to be displaced by the unusual 7alpha-methoxy of the inhibitor. Instead, the 7alpha-group appears to inhibit by preventing the formation of the deacylation transition state through steric hindrance. From an inhibitor design standpoint, we note that the best of the reversible inhibitors, a ceftazidime-like boronic acid compound, binds to CTX-M-16 with a K(i) value of 4 nM. When used together in cell culture, this inhibitor reversed cefotaxime resistance in CTX-M-producing bacteria. The structure of its complex with CTX-M enzyme and the structural view of the reaction coordinate described here provide templates for inhibitor design and intervention to combat this family of antibiotic resistance enzymes.
Insights
CTX-M enzymes, a major cause of antibiotic resistance, were studied using X-ray crystallography. Researchers identified key structural changes and a novel inhibition mechanism, paving the way for new drug designs against resistant bacteria.
Area of Science:
- Biochemistry
- Structural Biology
- Microbiology
Background:
- CTX-M enzymes are a significant and growing group of extended-spectrum beta-lactamases (ESBLs).
- These enzymes confer resistance to penicillins and various generations of cephalosporins.
- Effective inhibitors and detailed mechanistic understanding of CTX-M enzymes are limited.
Purpose of the Study:
- To elucidate the detailed mechanism of CTX-M enzymes.
- To characterize the enzyme's reaction coordinate using X-ray crystallography.
- To provide structural templates for designing novel inhibitors against CTX-M-mediated antibiotic resistance.
Main Methods:
- X-ray crystal structures of CTX-M enzymes.
- Complex formation with transition-state analogues and beta-lactam inhibitors.
- Analysis of enzyme conformational changes along the reaction coordinate.
Main Results:
- Observed conformational changes in catalytic residues Lys73 and Glu166.
- Discovered that cefoxitin's 7alpha-methoxy group inhibits by sterically hindering deacylation, not by displacing catalytic water.
- Identified a ceftazidime-like boronic acid inhibitor with a 4 nM K(i) value against CTX-M-16.
- Demonstrated reversal of cefotaxime resistance in bacteria using the boronic acid inhibitor.
Conclusions:
- The study provides a detailed structural view of the CTX-M enzymatic mechanism.
- The findings offer insights into inhibitor design strategies targeting CTX-M enzymes.
- Structural data can guide the development of new interventions against antibiotic resistance conferred by CTX-M enzymes.
Related Concept Videos
Development of Antibiotic Resistance
Production of Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

